Technology Transfer at the U.S. Environmental Protection Agency’ Cincinnati Environmental Research Center

1990 ◽  
Vol 40 (3) ◽  
pp. 317-321
Author(s):  
Larry Fradkin ◽  
Francis T. Mayo
1989 ◽  
Vol 21 (6-7) ◽  
pp. 685-698
Author(s):  
J. J. Convery ◽  
J. F. Kreissl ◽  
A. D. Venosa ◽  
J. H. Bender ◽  
D. J. Lussier

Technology transfer is an important activity within the ll.S. Environmental Protection Agency. Specific technology transfer programs such as the activities of the Center for Environmental Research Information, the Innovative and Alternative Technology Program, as well as the Small Community Outreach Program are used to encourage the utilization of cost-effective municipal pollution control technology. Case studies of three technologies including a plant operations diagnostic/remediation methodology, alternative sewer technologies and ultraviolet disinfection are presented. These case studies are presented retrospectively in the context of a generalized concept of how technology flows from science to utilization which was developed in a study by Allen (1977). Additional insights from this study are presented on the information gathering characteristics of engineers and scientists which may be useful in designing technology transfer programs. The recognition of the need for a technology or a deficiency in current practice are important stimuli other than technology transfer for accelerating the utilization of new technology.


1999 ◽  
Vol 01 (03) ◽  
pp. 329-347 ◽  
Author(s):  
REBECCA A. EFROYMSON

The Toxic Substances Control Act (TSCA) is the legislation used by the U.S. Environmental Protection Agency to regulate releases of genetically engineered microorganisms. The rule defining the scope of the notification requirements for releases of microbial products of biotechnology was published in April 1997. The Environmental Protection Agency (EPA) had some latitude regarding the extent to which various categories of microorganisms would be regulated, but the agency was constrained by requirements of TSCA and an interagency agreement about how to regulate products of biotechnology. This paper investigates the extent to which the scope of oversight is based on risk. A risk-based rule is defined as one where the reporting requirements are based on potential for exposure or expected adverse effects. The evolution of the rule is described, and risk-based components are discussed. In conclusion, the scope of oversight of microbial releases is determined to be based on risk to the extent that legislation and institutional constraints permit.


Sign in / Sign up

Export Citation Format

Share Document